Ataraxis is an unclaimed profile.
If you work at Ataraxis, sign up or log in to claim the profile today.
Ataraxis
Ataraxis
Ataraxis AI develops AI-powered diagnostic tools to enhance cancer prognosis and treatment selection. Their flagship product, Ataraxis Breast, is an AI-native test that analyzes multi-modal patient data, including standard pathology slides, to predict breast cancer recurrence risk and assist in personalizing treatment decisions.
Product Overview
Ataraxis AI develops AI-powered diagnostic tools to enhance cancer prognosis and treatment selection. Their flagship product, Ataraxis Breast, is an AI-native test that analyzes multi-modal patient data, including standard pathology slides, to predict breast cancer recurrence risk and assist in personalizing treatment decisions. This test has been clinically validated with data from over 8,000 patients across 15 institutions, demonstrating improved accuracy over traditional genomic assays.
Customers Served
Categories
Company Info
HQ Location
New York, New York
Founded
2023
Headcount
1-10
Total Funding
$4M
Latest Round
Seed
Latest Round
10/31/2024
Company Socials
Genomind
Genomind
Company Info
Founded: 2009
Headcount: 51-200
Customers
Verified Customers: 4
Customers Served: Diagnostic Labs, Hospital / Health System, Ambulatory Practice
Product Overview
Security and Compliance Certifications: HIPAA
Genomind uses pharmacogenetic testing to tailor medication choices based on an individual's genetic profile. Their services include precision medicine software to identify gene-drug interaction risks, adjustment of treatment plans, and consultations with PharmD and PhD experts for healthcare providers.
Other Categories
UMethod
RestoreU by UMethod
Company Info
Founded: 2013
Headcount: 11-50
Customers
Verified Customers: 1
Customers Served: Digital Health Provider, Ambulatory Practice, Hospital / Health System
Product Overview
RestoreU, developed by uMETHOD Health, is an AI-driven platform designed to manage and improve cognitive health, particularly targeting conditions like dementia and Alzheimer's disease. The platform utilizes advanced algorithms to analyze over 50 risk factors from diverse data sources, including lab results, genetic information, medications, comorbidities, and patient lifestyle. It generates personalized care plans that address these risk factors, helping physicians provide tailored treatment to their patients.
Other Categories